OUR BLOGS
Check out our latest and upcoming Blogs.
Contact Us
January 13 2021
Canagliflozin
Canagliflozin is the anhydrous form of canagliflozin, a C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. It was initially approved by the FDA in 2013 for the management of diabetes and later approved in 2018 for a second indication of reducing the risk of cardiovascular events in patients diagnosed with type2diabetesmellitus.
Read More ›January 11 2021
Cabazitaxel
Cabazitaxel is a semi-synthetic derivative of the natural Taxoid 10-deacetylbaccatin III with potential antineoplastic activity. Cabazitaxel is used to treat people with prostatecancer that has progressed despite treatment with docetaxel. It was approved by Food and Drug Administration (FDA) in 2010.
Read More ›January 2 2021
Bortezomib
Bortezomib is a dipeptide boronic acid derivative and proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma. The boron atom in bortezomib binds the catalytic site of the 26S proteasome with high affinity and specificity. In May 2003, bortezomib became the first anticancerproteasome inhibitor that was approved by the FDA.
Read More ›November 10 2020
Bupropion
Bupropion is an aminoketone with antidepressant activity. Bupropion is a unicyclic aminoketone that belongs to the class of substituted cathinones and the more general class of substituted phenethylamines. Bupropion is a medication primarily used to treat major depressivedisorder and to support smokingcessation. It was approved by the USFDA as an antidepressant.
Read More ›November 9 2020
Budesonide
Budesonide is used to treat inflammatory conditions of the lungs and intestines such as asthma, COPD, Crohn's disease, and ulcerative colitis. Budesonide belongs to the class of organiccompounds known as 21-hydroxysteroids. During the 2020 COVID-19 pandemic, researchers observed that patients already prescribed inhaled corticosteroids appeared to develop less serious illness when diagnosed with covid19
Read More ›November 1 2020
Brivaracetam
Brivaracetam is an orally bioavailable levetiracetam derivative, with anticonvulsant activity. Brivaracetam is used in the treatment of partial-onset seizures. Brivaracetam was approval on February 19, 2016.
Read More ›October 30 2020
Brexpiprazole
Brexpiprazole is a novel D2 dopamine and serotonin 1A partial agonist, called serotonin-dopamine activity modulator (SDAM), and a potent antagonist of serotonin 2A receptors, noradrenergic alpha 1B and 2C receptors. Brexpiprazole is an atypical antipsychotic used in the treatment of schizophrenia and major depressivedisorders. In January 2018, it was approved .
Read More ›October 29 2020
Bosutinib
Bosutinib is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Bosutinib is a Bcr-Abl kinase inhibitor for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). Bosutinib was approved on September 4, 2012.
Read More ›October 28 2020
Ampicillin
Ampicillin is a broad-spectrum, semi-synthetic, beta-lactam penicillin antibiotic with bactericidalactivity. Ampicillin is an antibiotic used to prevent and treat a number of bacterialinfections, such as infections, urinary, meningitis, salmonellosis, and endocarditis. Ampicillin was discovered in 1958 and came into commercial use in 1961.
Read More ›October 26 2020
Almotriptan
Almotriptan is a sulfonamide triptan with extracerebral, intracranial vasoconstrictor activity. Almotriptan is a triptan drug for the treatment of migraineheadaches. It was patented in 1992 and approved for medical use in 2000.
Read More ›